Literature DB >> 12135390

ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA.

Jennifer E Fraylick1, Matthew J Riese, Timothy S Vincent, Joseph T Barbieri, Joan C Olson.   

Abstract

Exoenzyme S (ExoS) is a bifunctional virulence factor directly translocated into eukaryotic cells by the type III secretory process of Pseudomonas aeruginosa. Bacterial translocation of ExoS into epithelial cells is associated with diverse effects on cell function, including inhibition of growth, alterations in cell morphology, and effects on adherence processes. Preferred substrates of the ADP-ribosyltransferase (ADPRT) portion of ExoS include low molecular weight G-proteins (LMWG-proteins) in the Ras family. In examining the ADP-ribosylation and functional effects of ExoS on RalA, ExoS was found to ADP-ribosylate endogenous RalA and recombinant RalADeltaCAAX at multiple sites, with Arg52 identified as the preferred site of ADP-ribosylation. The binding of RalA to the Ral binding domain (RBD) of its downstream effector, RalBP1, was inhibited by bacterially translocated ExoS, indicating an effect of ExoS on cellular RalA function. In vitro analyses confirmed that ADP-ribosylation of RalA directly interfered with its ability to bind to the RBD of RalBP1. The studies support the fact that RalA is a cellular substrate of bacterially translocated ExoS and that ADP-ribosylation by ExoS affects RalA interaction with its downstream effector, RalBP1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135390     DOI: 10.1021/bi025826n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.

Authors:  Claudia L Rocha; Elizabeth A Rucks; Deanne M Vincent; Joan C Olson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Characterization of an ExoS Type III translocation-resistant cell line.

Authors:  Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa.

Authors:  Michelle Cisz; Pei-Chung Lee; Arne Rietsch
Journal:  J Bacteriol       Date:  2007-11-26       Impact factor: 3.490

4.  The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization.

Authors:  A Kierbel; A Gassama-Diagne; K Mostov; J N Engel
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

5.  Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells.

Authors:  Jinghua Jia; Yanping Wang; Lei Zhou; Shouguang Jin
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

6.  Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo.

Authors:  Russell E Vance; Arne Rietsch; John J Mekalanos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Examining the role of actin-plasma membrane association in Pseudomonas aeruginosa infection and type III secretion translocation in migratory T24 epithelial cells.

Authors:  Dacie R Bridge; Karen H Martin; Elizabeth R Moore; Wendy M Lee; James A Carroll; Claudia L Rocha; Joan C Olson
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

8.  Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.

Authors:  Claudia L Rocha; Jenifer Coburn; Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

9.  Translocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS.

Authors:  Victoria Hritonenko; David J Evans; Suzanne M J Fleiszig
Journal:  Microbes Infect       Date:  2012-08-30       Impact factor: 2.700

10.  c-Jun NH2-terminal kinase-mediated signaling is essential for Pseudomonas aeruginosa ExoS-induced apoptosis.

Authors:  Jinghua Jia; Mounia Alaoui-El-Azher; Marie Chow; Timothy C Chambers; Henry Baker; Shouguang Jin
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.